Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBIS-I: Tamoxifen to Prevent Breast Cancer
NCT00002644Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Jan 1994
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Tamoxifen citrate with Placebo (2 arms). Primary endpoint: Incidence of breast cancer, including ductal carcinoma in situ at 10 years. Started Jan 1994; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002644.